Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
Open accessThe DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 9 sources its claims cite is checked for support yet.
Abstract
BACKGROUND: Positive association between obesity and survival after breast cancer was demonstrated in previous meta-analyses of published data, but only the results for the comparison of obese versus non-obese was summarised. METHODS: We systematically searched in MEDLINE and EMBASE for follow-up studies of breast cancer survivors with body mass index (BMI) before and after diagnosis, and total and cause-specific mortality until June 2013, as part of the World Cancer Research Fund Continuous Update Project. Random-effects meta-analyses were conducted to explore the magnitude and the shape of the associations. RESULTS: Eighty-two studies, including 213 075 breast cancer survivors with 41 477 deaths (23 182 from breast cancer) were identified. For BMI before diagnosis, compared with normal weight women, the summary relative risks (RRs) of total mortality were 1.41 [95% confidence interval (CI) 1.29-1.53] for obese (BMI >30.0), 1.07 (95 CI 1.02-1.12) for overweight (BMI 25.0-<30.0) and 1.10 (95% CI 0.92-1.31) for underweight (BMI <18.5) women. For obese women, the summary RRs were 1.75 (95% CI 1.26-2.41) for pre-menopausal and 1.34 (95% CI 1.18-1.53) for post-menopausal breast cancer. For each 5 kg/m(2) increment of BMI before, <12 months after, and ≥12 months after diagnosis, increased risks of 17%, 11%, and 8% for total mortality, and 18%, 14%, and 29% for breast cancer mortality were observed, respectively. CONCLUSIONS: Obesity is associated with poorer overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained. Being overweight is also related to a higher risk of mortality. Randomised clinical trials are needed to test interventions for weight loss and maintenance on survival in women with breast cancer.
Checked 2026-10-11 · 1 reference not checked yet
Overview
CoChat Summary
## TL;DR
This systematic review and meta-analysis of 82 follow-up studies found that higher BMI was associated with worse overall and breast cancer survival in women with breast cancer, whether BMI was measured before diagnosis, <12 months after, or ≥12 months after diagnosis. It also found some increased mortality risk in overweight and underweight women and evidence of a J-shaped BMI–total mortality relationship.
## Key findings
- Across 79 publications from 82 follow-up studies, the meta-analyses included 41,477 deaths (23,182 from breast cancer) among 213,075 breast cancer survivors.
- For total mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.41 (95% CI 1.29–1.53; 21 studies)
- <12 months after diagnosis: RR 1.23 (95% CI 1.12–1.33; 24 studies)
- ≥12 months after diagnosis: RR 1.21 (95% CI 1.06–1.38; 5 studies)
- For breast cancer mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.35 (95% CI 1.24–1.47; 22 studies)
- <12 months after diagnosis: RR 1.25 (95% CI 1.10–1.42; 12 studies)
- ≥12 months after diagnosis: RR 1.68 (95% CI 0.90–3.15; 2 studies; not statistically significant)
- Linear dose–response analyses showed increased risk per 5 kg/m² higher BMI:
- Total mortality: RR 1.17 before diagnosis, 1.11 <12 months after, 1.08 ≥12 months after
- Breast cancer mortality: RR 1.18 before diagnosis, 1.14 <12 months after
- The paper reports a J-shaped association for total mortality and notes that risks were also elevated in overweight and, in some analyses, underweight women.
## Methods
- Design: Systematic literature review and meta-analysis of follow-up studies of women with breast cancer.
- Data/sample: English-language articles from OVID MEDLINE and EMBASE through 30 June 2013, plus hand-searching; included studies had to report BMI and total or cause-specific mortality. Final meta-analyses used 79 publications from 82 follow-up studies.
- Main analysis: Random-effects categorical and dose–response meta-analyses, including non-linear dose–response models; heterogeneity assessed with Cochran Q and I², with subgroup/meta-regression, sensitivity analyses, and publication-bias checks using Egger’s test and funnel plots.
## Limitations
- The paper states that most studies did not adjust for co-morbidities and did not assess intentional weight loss; body weight and treatment information were often incomplete or unavailable.
- It notes that reverse causation may have affected studies assessing BMI in women with cancer and other illnesses, and that survival bias in survivor cohorts may underestimate associations.
- The text also says the review could not analyze race/ethnicity or treatment types because too few studies reported them; this is an evident limitation of the evidence base, not just the review.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 9 Not checked · 67 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BMI was significantly associated with breast cancer mortality.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
states an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The current systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre and postmenopausal breast cancer, regardless of when BMI is ascertained.”
- Also stated in: § discussion · boosted
“The present systematic literature review and meta-analysis of follow-up studies clearly supports that, in breast cancer survivors, higher BMI is consistently associated with lower overall and breast cancer survival, regardless of when BMI is ascertained.”
- Also stated in: § discussion · plain
“In conclusion, the present systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > Abstract
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § discussion · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared with normal weight women, for BMI before diagnosis, the summary RRs were 1.35 (95% CI 1.24–1.47, 22 studies) for obese women, 1.11 (95% CI 1.06–1.17, 21 studies) for overweight women, and 1.02 (95% CI 0.85–1.21, 8 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
47 more claims
Create a free account to see all 76 claims and to verify the 9 references still open.
- The quote only partly states this claim. 4
- It may state two separate claims as one. 16
- Probably not a substantial claim. 10
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“statistical analysis Categorical and dose-response meta-analyses were conducted using random-effects models to account for between-study heterogeneity[18].”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“To assess heterogeneity, we computed the Cochran Q test and I 2 statistic[35].”
MethodFood, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050 · cited 1×
“be obese and 958 million were overweight in 2008[3].”
BackgroundPublication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282 · cited 1×
“Small study or publication bias was examined by Egger’s test[36] and visual inspection of the funnel plots.”
MethodNutrition and physical activity guidelines for cancer survivors
Rock, C. L., Doyle, C., Demark‐Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., Bandera, E. V., Hamilton, K. K., Grant, B., McCullough, M., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21142 · Cited by 1,995
Self-citationGeneralized Least Squares for Trend Estimation of Summarized Dose–response Data
Orsini, N., Bellocco, R., & Greenland, S. (2006) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600103 · Cited by 1,241 · cited 1×
“generalised least-squares for trend estimation[25].”
The use of fractional polynomials to model continuous risk variables in epidemiology
Royston, P., Ambler, G., & Sauerbrei, W. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.5.964 · Cited by 1,066 · cited 1×
“The non-linear dose-response relationship between BMI and mortality was examined using the best-fitting second order fractional polynomial regression model[23], defined as the one with the lowest deviance.”
MethodFasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Protani, M., Coory, M., & Martin, J. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0990-0 · Cited by 962 · cited 3×
“A review published in 2010 reported statistically significant increased risks of 33% of both total and breast cancer mortality for obesity versus non-obesity around diagnosis[7].”
Background
Research works printed but not linked: 2
- Tobias A Assessing the influence of a single study in meta-analysis Stata Tech Bull 1999 47 15 17
- Donegan WL Jayich S Koehler MR The prognostic implications of obesity for the surgical cure of breast cancer Breast 1978 4 14 17
Cited by
Items 701–800 of 1,000
Danthala, M., Rajesh, G. R., Gundeti, S., Raju, G. S., Chandran, P. A., & Srinivas, M. L. (2018) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/ijmpo.ijmpo_203_16 · Cited by 8
“Obese women have on average a 33% higher risk of total (95% confidence interval [CI]: 21%–47%) and breast cancer‐specific mortality (95% CI: 19%–50%) compared to nonobese women.[6] Adipose tissue is now recognized as metabolically active and a source of adipose tissue‐derived hormones and cytokines (adipokines) such a…”
BackgroundL’Abbate, S., Russo, I., & Kusmic, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117843 · Cited by 8
İzol, V., Değer, M., Baltacı, S., Akgül, M., Selvi, İ., Özden, E., Süer, E., & Tansuğ, M. Z. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13750 · Cited by 8
Nguyen, T., Irwin, M. L., DeWan, A. T., Cartmel, B., Harrigan, M., Ferrucci, L. M., Sanft, T. B., Li, F., Lu, L., & Salinas, Y. D. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06151-5 · Cited by 8
Effect of body mass index on pharmacokinetics of paclitaxel in patients with early breast cancer
Gota, V., Nookala, M., Bonda, A., KARANAM, A. B., Shriyan, B., Kembhavi, Y., Gurjar, M., Patil, A., Singh, A., Goyal, N., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3865 · Cited by 8
Kim, S. W., Chun, M., Jung, Y. S., Oh, Y., Noh, O. K., & Cho, O. (2021) · Journal of Cancer · doi:10.7150/jca.59064 · Cited by 8
“BMI affects many aspects of breast cancer, including cancer occurrence, the determination of intrinsic subtypes, and prognosis [3-10].”
BackgroundThe Role of Obesity and Inflammation in Breast Cancer Recurrence
Chew, S. M., Liu, B., Shen, S., & Iyengar, N. M. (2024) · Current Breast Cancer Reports · doi:10.1007/s12609-024-00550-5 · Cited by 8
Prognosis of Breast Cancer Patients Underwent Surgery in a Developing Country
Traoré, B., Touré, A. F., Sy, T., Dieng, M. M., Condé, M., Deme, A., & Keita, N. (2015) · Journal of Cancer Therapy · doi:10.4236/jct.2015.69088 · Cited by 8
“[30], showed the associations of obesity with an unfavorable overall and breast cancer survival in pre and post-menopausal breast cancer, regardless of when body mass index is ascertained.”
BackgroundMajid, H. A., Keow, L. P., Islam, T., Su, T. T., Cantwell, M. M., Taib, N. A. M., Taib, N. A. M., Bhoo‐Pathy, N., Majid, H. A., Nahar, A. M., et al. (2017) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2017.05.024 · Cited by 8
Life course evolution of body size and breast cancer survival in the E3N cohort
His, M., Guélennec, M. L., Mesrine, S., Boutron‐Ruault, M., Clavel‐Chapelon, F., Fagherazzi, G., & Dossus, L. (2017) · International Journal of Cancer · doi:10.1002/ijc.31177 · Cited by 8
Enewold, L., Penn, D. C., Stevens, J. L., & Harlan, L. C. (2018) · Cancer Causes & Control · doi:10.1007/s10552-018-1045-9 · Cited by 8
Hughes, T. M., Palmer, E. N., Capers, Q., Abdel‐Misih, S., Harzman, A. E., Beal, E. W., Woelfel, I. A., Noria, S. F., Agnese, D. M., Dillhoff, M. E., et al. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6564-9 · Cited by 8
Obesity and Prognostic Variables in Colombian Breast Cancer Patients: A Cross-Sectional Study
López, J. C., Zapata, A. F., & Trespalacios, E. M. V. (2017) · International Journal of Breast Cancer · doi:10.1155/2017/9574874 · Cited by 8
PTGS2 polymorphism rs689466 favors breast cancer recurrence in obese patients
Freitas-Alves, D. R., Vieira-Monteiro, H. D. A., Piranda, D. N., Sobral‐Leite, M., da Silva, T. S. L., Bergmann, A. K., Valença, S. S., Perini, J. A., & Vianna‐Jorge, R. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0374 · Cited by 8
Ekenga, C. C., Wang, X., Pérez, M., Schootman, M., & Jeffe, D. B. (2019) · Journal of Women s Health · doi:10.1089/jwh.2018.7638 · Cited by 8
Marpaung, M. R. A., Khambri, D., & Asterina, A. (2021) · Jurnal Ilmu Kesehatan Indonesia · doi:10.25077/jikesi.v2i1.306 · Cited by 8
Newlands, R. S. N., Ntessalen, M., Clark, J., Fielding, S., Hoddinott, P., Heys, S. D., McNeill, G., & Craig, L. C. A. (2019) · Pilot and Feasibility Studies · doi:10.1186/s40814-019-0405-x · Cited by 7
Saroosh, R., Aḥmad, N., Israr, B., Arif, S., Itrat, N., & Ahmad, A. M. R. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1624896 · Cited by 7
Ligibel, J. A., Zheng, Y. H., Barry, W. T., Sella, T., Ruddy, K. J., Greaney, M. L., Rosenberg, S. M., Emmons, K. M., & Partridge, A. H. (2023) · Cancer · doi:10.1002/cncr.34779 · Cited by 7
“Obesity at the time of breast cancer diagnosis has been associated with an increased risk of breast cancer–specific and all‐cause mortality in premenopausal women with early breast cancer.(5,6) Inactivity after breast cancer diagnosis also has been linked to an increased risk of breast cancer–specific and all‐cause mo…”
BackgroundNair, N. M., Vaughn, C. B., Ochs‐Balcom, H. M., Nie, J., Trevisan, M., & Freudenheim, J. L. (2023) · Cancer Causes & Control · doi:10.1007/s10552-023-01774-z · Cited by 7
“Such effects may be modified by body mass composition, which has been previously associated with both sleep disturbance and breast cancer mortality [23, 24].”
Kim, J. S., Song, J., Choi, S., & Park, S. M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1259292 · Cited by 7
Dongur, L. P., Samman, Y., Golovko, G., Botnar, K., Kueht, M., Moffett, J., & Samreen, S. (2024) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2024.06.010 · Cited by 7
Xu, K., Wang, X., Zhou, C., Zuo, J., Zeng, C., Zhou, P., Zhang, L., Gao, X., & Wang, X. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1499188 · Cited by 7
Jung, Y. S., Ahn, H. K., Shin, H.-Y., Hong, J. H., & Rim, C. H. (2025) · Cancer Research and Treatment · doi:10.4143/crt.2025.110 · Cited by 7
“In the context of early-stage breast cancer (EBC), particularly HR+ subtypes, obesity has been consistently associated with a worse prognosis [5].”
Blyth, R. R. R., Laversin, S. A., Foxall, R. B., Savva, C., Copson, E., Cutress, R., Birts, C. N., & Beers, S. A. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00766-3 · Cited by 7
“Furthermore, regardless of menopausal status or age, BC patients with obesity have a worse prognosis compared to patients with a healthy BMI 3,4 .”
Fedele, P., Stucci, L. S., Landriscina, M., Morritti, M. G., Giuliani, F., Moraca, L., Cairo, G., Ardito, R., Giampaglia, M., Bilancia, D., et al. (2025) · Cancers · doi:10.3390/cancers17213554 · Cited by 7
Coradini, D., Orenti, A., Venturelli, E., Cavalleri, A., Biganzoli, E. M., & Oriana, S. (2018) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyy012 · Cited by 7
“In particular, it has been shown that in postmenopausal women, accumulation of fat in the abdomen (visceral obesity) due to the redistribution of adipose tissue following the decline in ovarian function (9), is associated with increased risk of distant recurrences (10) and bad prognosis (11).”
BackgroundInfluentialKim, J. H., Yoon, K. H., Hur, H., Park, S., Kim, J. Y., Park, H. S., Kim, S. I., Cho, Y. U., & Park, B. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-05091-x · Cited by 7
Cárdenas-Cárdenas, E., Tenorio‐Torres, A., Méndez, J. P., Orozco-Arguelles, L., Leal-García, M., Coral‐Vázquez, R. M., Vega-García, C. C., Bautista‐Piña, V., & Canto, P. (2021) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2021.151705 · Cited by 7
Sexual Perception in Spanish Female Breast Cancer Survivors. Cross-Sectional Survey
Torres-Balanzá, S., Fuentes‐Aparicio, L., Horno, S. M.-D., Aspas, A. M., & Sempere‐Rubio, N. (2022) · Clinical Breast Cancer · doi:10.1016/j.clbc.2022.10.011 · Cited by 7
Aznab, M., Shojae, S., Golpazir, A., pia, K. E., & Rezaei, M. (2022) · Archives of Breast Cancer · doi:10.32768/abc.202310166-73 · Cited by 7
Wang, H., Yee, D., Potter, D. A., Jewett, P. I., Yau, C. S. F., Beckwith, H. C., Watson, A. P., O’Grady, N., Wilson, A. F., Brain, S., et al. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-023-07214-5 · Cited by 7
“Although several prospective studies and meta-analyses have reported that increased body weight was associated with poorer breast cancer outcomes such as OS and EFS, especially in postmenopausal women [15, 23, 24], it has been a challenge to clarify the underlying cause.”
ResultFajardo-Espinoza, F. S., Cabrera-Nieto, S. A., Espadas-Vargas, A. L., Pérez-Camargo, D. A., Mohar, A., & Cruz‐Ramos, M. (2024) · Nutrition · doi:10.1016/j.nut.2024.112524 · Cited by 7
Complex Interplay Between Obesity and BRCA1/2‐Associated Breast Cancer: An Overview
Giordano, C., Puzzo, M., Malivindi, R., Cristofaro, D., Gelsomino, L., Bonofiglio, D., Capalbo, C., Andò, S., Barone, I., & Catalano, S. (2025) · Obesity Reviews · doi:10.1111/obr.13969 · Cited by 7
Obesity and Type 2 Diabetes: Preventing Associated Complications
Wimalawansa, S. J. (2015) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2015.02.00047 · Cited by 7
Karpińska, A., Safranow, K., Kładny, J., & Sulżyc‐Bielicka, V. (2015) · Polish Journal of Surgery · doi:10.1515/pjs-2015-0047 · Cited by 7
Hepatosteatosis may predict late recurrence of breast cancer: A single-center observational study
Kuş, T., Çınkır, H. Y., Aktaş, G., & Abalı, H. (2019) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2019.01.002 · Cited by 7
Jiang, J., Guo, Z., Xu, J., Sun, T., & Zheng, X. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s250619 · Cited by 7
Shakri, A. R., Zhong, T. J., Ma, W., Coker, C., Hegde, R., Scholze, H., Chin, V., Szabolcs, M. J., Hibshoosh, H. H., Tanji, K., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3242 · Cited by 7
Orozco-Arguelles, L., Santos, S. D. L., Tenorio‐Torres, A., Méndez, J. P., Leal-García, M., Coral‐Vázquez, R. M., Vega-García, C. C., Bautista‐Piña, V., Tejeda, M. E., Cárdenas-Cárdenas, E., et al. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-206471 · Cited by 7
Diet and Prognosis in Women with Breast Cancer
McTiernan, A. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1506 · Cited by 7
“Women who have obesity, are insufficiently physically active, or who have metabolic abnormalities including diabetes, prediabetes, or hyperglycemia/insulinemia have poorer survival compared with other women with breast cancer (2, 4, 5).”
BackgroundSelf-citationAssociation between weight change and breast cancer prognosis
Zhang, Y., Liang, Z., Li, Y., Lin, Y., Liu, Q., Xie, X., Tang, L.-Y., & Ren, Z. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06592-6 · Cited by 7
“There is accumulating evidence that being obese or overweight before diagnosis impacts adversely on breast cancer prognosis [4].”
BackgroundJendretzki, J., Henniger, D., Schiffmann, L., Wolz, C., Kollikowski, A., Meining, A. G., Einsele, H., Winkler, M., & Löffler, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1033265 · Cited by 7
“, considered a recognized risk factor for postmenopausal breast cancer (28).”
BackgroundFGFR1 Signaling Facilitates Obesity-Driven Pulmonary Outgrowth in Metastatic Breast Cancer
Kulkoyluoglu‐Cotul, E., Safdar, M. H., Paez, S. J., Kulkarni, A., Ayers, M. G., Lin, H., Xianyu, Z., Teegarden, D., Hursting, S. D., & Wendt, M. K. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0955 · Cited by 7
App-Based Lifestyle Intervention (PINK! Coach) in Breast Cancer Patients—A Real-World-Data Analysis
Wolff, J., Smollich, M., Wuelfing, P., Mitchell, J., Wuerstlein, R., Harbeck, N., & Baumann, F. T. (2024) · Cancers · doi:10.3390/cancers16051020 · Cited by 7
Change in Body Mass Index After Breast Reconstruction and Associated Complications.
Applebaum, M. A., Miller, B. T., Lopez, J. J., Doren, E. L., Laronga, C., & Smith, P. D. (2015) · PubMed Central · Cited by 7
Indice de masse corporelle et facteurs pronostiques du cancer du sein
Boivin, L., Diguisto, C., Chas, M., Bédouet, L., Etienne, C. S., Arbion, F., Body, G., & Ouldamer, L. (2017) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2017.02.008 · Cited by 7
Goupille, C., Ouldamer, L., Pinault, M., Guimares, C., Arbion, F., Jourdan, M. L., & Frank, P. G. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa432 · Cited by 7
Martínez-Ramírez, M., Coral‐Vázquez, R. M., Tenorio, A., Méndez, J. P., Benítez-Granados, J., Asis, A. M., Cuevas, S. R., Reyes, C. D., Erazo-Valle, A., & Canto, P. (2017) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2017.09.001 · Cited by 7
Hansra, D. M., McIntyre, K., Ramdial, J., Sacks, S. M., Patrick, C. S., Cutler, J. J., McIntyre, B., Feister, K., Miller, M., Taylor, A. K., et al. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/8081018 · Cited by 7
“Furthermore, there have been studies showing thatweight loss or gain increases mortality risk in survivors suggesting that weight maintenance is optimal [133].”
BackgroundAerobic Fitness is a Predictor of Body Composition in Women With Breast Cancer at Diagnosis
Bortolozo, H. I., Derchain, S., VECHIN, F. C., MAGINADOR, G. F., Santos, I. S., Torresan, R. Z., dos Santos, P. D. N. S., Sarian, L. O., & Conceição, M. S. (2020) · Clinical Breast Cancer · doi:10.1016/j.clbc.2020.10.001 · Cited by 7
Ballinger, T. J., Jiang, G., Kassem, N., Radovich, M., & Schneider, B. P. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3341 · Cited by 7
“Obesity, defined by body mass index (BMI), is significantly associated with worse overall and disease-specific survival in early-stage breast cancer (1, 2).”
Application and evaluation of mobile nutrition management service for breast cancer patients
Choi, J. H., Park, S., Kwon, H. J., & Lee, H. (2020) · Journal of Nutrition and Health · doi:10.4163/jnh.2020.53.1.83 · Cited by 7
Muñoz-Ayala, A., Chimal‐Vega, B., & García‐González, V. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.05.011 · Cited by 6
Klement, R. J., Joos, F., Reuss-Borst, M. A., & Kämmerer, U. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.02.013 · Cited by 6
Liu, W., Yan, M., Fan, Z., Ma, Z., Zhu, Y., Chang, H., Jiang, R., & Ren, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-98625-5 · Cited by 6
“However, the directionality of this relationship seemed to differ by menopausal status 29,30 .”
Lynch, S. E., Crawford, C., Hunt, A., Sligh, L., Zhang, Y., Norian, L. A., Larimer, B. M., Lapi, S. E., & Sorace, A. G. (2025) · PubMed Central · doi:10.2967/jnumed.124.268938 · Cited by 6
Association of different types of dietary fatty acids with breast cancer, a case-control study
Gholamalizadeh, M., Shahdoosti, H., Bahadori, E., Bourbour, F., Akbari, M. E., Rastgoo, S., & Doaei, S. (2021) · Nutrition & Food Science · doi:10.1108/nfs-07-2021-0210 · Cited by 6
Cho, H. J., Song, S., Kim, Z., Youn, H. J., Cho, J., Min, J. W., Kim, Y. S., Choi, S., & Lee, J. E. (2022) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.13779 · Cited by 6
Aguiar, D., Ros, L., Pérez, D., Sanchez, L. C., Mori, M., Hernández, M., Vargas, A. M., Galván, S., Antonilli, C., & Saura, S. (2022) · Breast Disease · doi:10.3233/bd-210071 · Cited by 6
Bail, J. R., Wilson, J., Tipre, M., Duck, A. A., Hall, K. M., Akinyele, O., Bowman, T., Hardy, C. M., Garner, M. J., Demark‐Wahnefried, W., et al. (2023) · Translational Behavioral Medicine · doi:10.1093/tbm/ibad062 · Cited by 6
Bellissimo, M. P., Carbone, S., He, J., Jordan, J. H., Ambale‐Venkatesh, B., Lima, J. A. C., LaRose, J. G., Salloum, F. N., Bandyopadhyay, D., & Hundley, W. G. (2023) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2023.10.004 · Cited by 6
Ma, L., Liu, A., Gao, J., & Zhao, H. (2023) · Open Life Sciences · doi:10.1515/biol-2022-0748 · Cited by 6
“Our fi ndings are consistent with the current majority of literature [12,14 – 17], some based on Western populations [20,21] and others based on Asian populations such as Japan [6], Korea [22 – 24] and China [25], that overweight and obesity are associated with poorer survival of breast cancer…”
BackgroundMethodResultPoggio, F. B., Blondeaux, E., Tagliamento, M., Perachino, M., Nardin, S., Conte, B., Giuliano, M., Arpino, G., Laurentiis, M. D., Gravina, A., et al. (2024) · ESMO Open · doi:10.1016/j.esmoop.2024.103650 · Cited by 6
Yum, C., Andolino, C. J., Larrick, B., Sheeley, M. P., & Teegarden, D. (2024) · Nutrients · doi:10.3390/nu16183153 · Cited by 6
“…cancer in postmenopausal women Similarly, a meta-analysis shows that high BMI is associated with lower survival in pre-and post-menopausal breast cancer patients [2], and Mohr et al. have demonstrated that serum 25(OH)D level is inversely correlated to the risk of breast cancer-related death [12].”
BackgroundEffects of BMI on prognosis, disease-free survival and overall survival of breast cancer
Zangouri, V., Balaneji, S. S., Golmoradi, R., Kafili, E., Bologhi, S., Mousavi, S. A., Hesar, A. A., & Amestejani, M. (2025) · BMC Cancer · doi:10.1186/s12885-025-13638-7 · Cited by 6
García‐Estévez, L., Bardia, A., Rugo, H. S., Carey, L., Dieras, V. C., Loibl, S., Piccart, M. J., Gianni, L., Kalinsky, K. M., O’Shaughnessy, J., et al. (2025) · ESMO Open · doi:10.1016/j.esmoop.2025.105294 · Cited by 6
Mujeres afectadas por cáncer de mama—Recomendaciones para el seguimiento
Poma, P. A. (2017) · Revista Peruana de Ginecología y Obstetricia · doi:10.31403/rpgo.v63i1962 · Cited by 7
Baker, H. A., Fabian, C. J., Hastings, R. C., Dixon, D. A., Nydegger, J. L., Phillips, T. A., Powers, K. R., & Kimler, B. F. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05251-7 · Cited by 6
Cárdenas-Cárdenas, E., Tenorio‐Torres, A., Méndez, J. P., Orozco-Arguelles, L., Leal-García, M., Tejeda, M. E., Morales, A., & Canto, P. (2020) · Women & Health · doi:10.1080/03630242.2020.1812791 · Cited by 6
Meyer, D. M., Pastor‐Villaescusa, B., Michel, S., Hauner, H., & Hauner, D. (2022) · BMC Cancer · doi:10.1186/s12885-022-10274-3 · Cited by 6
Jiang, C., Xiu, Y., Zhang, S., Yu, X., Qiao, K., & Huang, Y. (2022) · Disease Markers · doi:10.1155/2022/8044550 · Cited by 6
Alsabry, A., Algabri, M. N. A., & Ahsan, A. M. (2023) · مجلة جامعة صنعاء للعلوم التطبيقية والتكنولوجيا · doi:10.59628/jast.v1i2.361 · Cited by 6
Cava, E., Spadaccini, D., Aimaretti, G., Marzullo, P., Cavigiolo, B., Farinelli, D., Gennari, A., Saggia, C., Carbonelli, M. G., Riso, S., et al. (2023) · Cancers · doi:10.3390/cancers15174401 · Cited by 6
“Although evidence suggests that overweight and obese BCSs have higher all-cause mortality and an increased risk of cancer recurrence with lower quality of life, there is still a lack of data to explain the impact of weight loss in this group of women and which dietary pattern would be the best approach for weight mana…”
BackgroundInfluentialPrediagnostic body size and breast cancer survival in the E3N cohort study
His, M., Fagherazzi, G., Mesrine, S., Boutron‐Ruault, M., Clavel‐Chapelon, F., & Dossus, L. (2016) · International Journal of Cancer · doi:10.1002/ijc.30158 · Cited by 6
Kobayashi, T., Tomomatsu, J., Fukada, I., Shibayama, T., Teruya, N., Ito, Y., Iwase, T., Ohno, S., & Takahashi, S. (2016) · BMC Cancer · doi:10.1186/s12885-016-2436-5 · Cited by 6
Chung, I. Y., Lee, J. W., Lee, J. S., Park, Y. R., Lee, S. B., Kim, H. J., Ko, B., Son, B. H., & Ahn, S. H. (2017) · The Breast · doi:10.1016/s0960-9776(17)30290-4 · Cited by 6
Dreher, M. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-59180-3_19 · Cited by 6
Is there an association between body mass index and 21-gene recurrence score?
Pomponio, M. K., Burkbauer, L., Goldbach, M. M., Keele, L. J., Allison, K. C., Li, Y. R., Nazarian, S. M., & Tchou, J. C. (2020) · Surgical Oncology · doi:10.1016/j.suronc.2020.01.007 · Cited by 6
Choi, J., Park, C. S., Seong, M.-K., Seol, H., Kim, J., Park, I., Noh, W. C., & Kim, H. (2020) · Journal of Breast Cancer · doi:10.4048/jbc.2020.23.e5 · Cited by 6
“The epidemiological link between obesity and hormonesensitive breast cancer is well established [15-17].”
BackgroundOzfiliz-Kilbas, P., Sönmez, Ö., Yerlikaya, P. O., Gürkan, A. Ç., Palavan-Ünsal, N., Onganer, P. U., & Arısan, E. D. (2021) · Cancers · doi:10.3390/cancers13215322 · Cited by 6
“Epidemiological studies so far include obesity, high body mass index (BMI), metabolic syndrome, alcohol, and hypercholesterolemia as risk factors for breast cancer [2,3].”
BackgroundTalbot, D. C., Moodie, E. E. M., & Diorio, C. (2022) · Statistics in Medicine · doi:10.1002/sim.9608 · Cited by 6
Obesity and Breast Cancer: Expanding the Hypothesis Space
Lohmann, A. E., & Goodwin, P. J. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa091 · Cited by 6
Orlandini, L. F. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-11062021-083252 · Cited by 6
High Risk of Metabolic Dysfunction in Nonobese Breast Cancer Survivors
da Silva-Filho, P. P. P., Buttros, D. D. A. B., Buttros, L. D. A. B., Esperança, G., Gubolino, P. L. F., Pessoa, E. C., Véspoli, H. D. L., & Nahás, E. A. P. (2025) · Clinical Breast Cancer · doi:10.1016/j.clbc.2025.01.009 · Cited by 5
Imbimbo, G., Pellegrini, M., Scagnoli, S., Pisegna, S., Rizzo, V., Gallicchio, C., Botticelli, A., & Molfino, A. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.02.031 · Cited by 5
Einfluss endogener und exogener Hormone in der Peri- und Postmenopause auf das Krebsrisiko
Schüler‐Toprak, S., Bausewein, L., & Ortmann, O. (2025) · Die Gynäkologie · doi:10.1007/s00129-025-05345-y · Cited by 5
García-Sáenz, J. Á., Spera, G., Pollán, M., Bermejo, B., Ruíz-Borrego, M., Chan, A., Martín, M., Zotano, Á. G., Calvo, L., Rodríguez-Lescure, Á., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.35432 · Cited by 5
“2,3 Several studies have investigated the relationship between body mass index (BMI) and outcomes in EBC patients treated with adjuvant chemotherapy, with conflicting findings, 4 – 7 and limited data on the long-term efficacy of taxanes among the different BMI categories.”
Environmental Modification of Adult Weight Loss, Physical Activity, and Diet Intervention Effects
Zenk, S. N., Tarlov, E., & Kraft, A. N. (2019) · Energy balance and cancer · doi:10.1007/978-3-030-18408-7_11 · Cited by 5
Беришвили, А. И., Кедрова, А. Г., Greyan, T. A., & Зайцева, О. В. (2022) · Tumors of female reproductive system · doi:10.17650/1994-4098-2022-18-3-40-51 · Cited by 5
Buro, A. W., Sauls, R., Stern, M., & Carson, T. L. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07756-w · Cited by 5
Zhang, H., Ma, S., Wang, Y., Chen, X., Li, Y., Wang, M., & Xu, Y. (2024) · iScience · doi:10.1016/j.isci.2024.109133 · Cited by 5
Lammers, S. W. M., Geurts, S. M. E., Hermans, K. E. P. E., van Hellemond, I. E. G., Swinkels, A. C. P., Smorenburg, C. H., van der Sangen, M. J. C., Kroep, J. R., Honkoop, A. H., van den Berkmortel, F. W. P. J., et al. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07411-w · Cited by 5
Wooster, M. E., Chen, L., Accordino, M. K., Sathe, C. M., Wright, J. D., & Hershman, D. L. (2025) · Breast Cancer Research and Treatment · doi:10.1007/s10549-025-07714-6 · Cited by 5
“Previous research has consistently indicated that overweight and obese breast cancer (BC) survivors face an elevated risk of cancer recurrence, as well as an increased likelihood of all-cause mortality, including deaths attributed to non-cancer etiologies such as cardiovascular disease (CVD) [1, 2].”
Xiong, G., He, D., Napier, D. L., Chen, J., Shi, H., Li, C., Hurley, P. J., Wang, C., Zhu, H., Zhou, C., et al. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02076-9 · Cited by 5
“Meta-analyses have shown that obesity is associated with poor survival in both pre-and post-menopausal breast cancer [2, 3].”
Vuong, V., Rao, V. S., & Ee, C. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354221137321 · Cited by 5
Comparing Lifestyle Modifications and the Magnitude of Their Associated Benefit on Cancer Mortality
Dougherty, T. P., & Meyer, J. E. (2023) · Nutrients · doi:10.3390/nu15092038 · Cited by 5
THE RELATIONSHIP BETWEEN BODY MASS INDEX AND LIFE SATISFACTION AMONG ADULT RUSSIANS
Gromova, D., & Алексеевна, Х. Н. (2023) · Social Aspects of Population Health · doi:10.21045/2071-5021-2023-69-1-5 · Cited by 5
da Silva, A. P. D. B. C., Jaques, H. D. S., Ferronato, M., Alves, F. M., Colleto, M. I. O., Ferreira, M. O., Orrutéa, J. F. G., Mezoni, M. F., da Silva, R. G. S., Rech, D., et al. (2023) · Current Research in Immunology · doi:10.1016/j.crimmu.2023.100059 · Cited by 5
Kaur, H., Pavela, G., Pekmezi, D., Rogers, L. Q., Cole, W., Parrish, K. B., Sayer, R. D., Wyatt, H. R., & Demark‐Wahnefried, W. (2023) · Nutrients · doi:10.3390/nu15234918 · Cited by 5
“Large meta-analyses have reported that a weight gain of 5 kg/m 2 is a significant predictor of cancer recurrence among breast and prostate cancer survivors [12,13].”
Background
Metadata
- Authors
- Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T.
- Affiliations
- Imperial College London (GB)
- Norwegian University of Science and Technology (NO)
- Rutgers, The State University of New Jersey (US)
- University of Leeds (GB)
- Fred Hutch Cancer Center (US)
- Oslo University Hospital (NO)
- Newcastle University (GB)
- Corresponding author
- Chan, D.S.M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 25
- Issue
- 10
- Pages
- 1901-1914
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC4176449
- OpenAlex
- W2149466392
- Cited by
- 1,165
- References
- 123
- Citations by year
- 2026: 57 · 2025: 69 · 2024: 97 · 2023: 117 · 2022: 132 · 2021: 117 · 2020: 121 · 2019: 103 · 2018: 97 · 2017: 98 · 2016: 85 · 2015: 58 · 2014: 12
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1878 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc-nd)
- HighWire Press Open Archive (submittedVersion)
- Funders
- World Cancer Research Fund International (2007/SP01)
- World Cancer Research Fund International/American Institute for Cancer Research
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- body mass index, breast cancer, obesity, overweight, underweight, survival, mortality, cause-specific mortality, menopausal status, weight loss interventions, cancer survivorship
- MeSH terms
- Breast Neoplasms, Female, Follow-Up Studies, Humans, Obesity, Prognosis, Risk Factors, Body Mass Index, Randomized Controlled Trials as Topic, MEDLINE, Survivors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.